2022 International Congress » Rating Scales

Meeting: 2022 International Congress

A modified Delphi panel to establish a threshold of meaningful progression on MDS-UPDRS Part III

D. Trundell, L. Barrett, R. Rogers, E. Davies, S. Zanigni, N. Pross, G. Pagano, T. Nikolcheva, S. Cano (Welwyn Garden City, United Kingdom)

A Patient-Centered Outcomes Survey in Parkinson’s Disease: Results of Cognitive Pre-Testing

D. Shah-Zamora, J. Karl, M. Tosin, G. Pal, G. Stebbins, C. Goetz, L. Verhagen (Chicago, USA)

Application of Goal Attainment Scale as a patient-centered assessment for cervical dystonia

P. Wongwan, P. Panyakaew, R. Bhidayasiri (Bangkok, Thailand)

Continuous wavelet transforms to improve the accuracy of motor assessments of Parkinson’s disease

T. Kosuri, J. Brasic (Baltimore, USA)

Development and validation of clinical scales for defining RBD severity in participants of the North American Prodromal Synucleinopathy (NAPS) consortium

A. Busicescu (Phoenix, USA)

Developmental Validity of the revised improved version of the Fragile X-associated Tremor Ataxia Syndrome Rating Scale (FXTAS-RS)

M. Tosin, G. Stebbins, C. Goetz, R. Hagerman, D. Hessl, M. Zolecki, P. Todd, M. Leehey, D. Hall (Chicago, USA)

Dysphagia and its relationship to medication intake in Parkinson’s disease

B. Labeit, E. Berkovich, I. Claus, M. Roderigo, AL. Schwake, D. Izgelov, D. Mimrod, S. Ahring, S. Oeleberg, P. Muhle, V. Zentsch, F. Wenninger, S. Suntrup-Krueger, R. Dziewas, T. Warnecke (Muenster, Germany)

Effect of Subthalamic Nucleus Stimulation (STN-DBS) on psychosocial function using the scale “SCOPA-PS” in patients with Parkinson’s Disease at the National Institute of Neurology and Neurosurgery in Mexico during 2007 to 2020.

D. Sandoval-Lopez, K. Velázquez-Leonel, C. Alcalá-Romero, S. Santillán-Herrera, F. Juárez-Tovar, J. Villarreal-Serrano (Mexico City, Mexico)

Estimating the Meaningful Within-Patient Change Threshold for the MDS-UPDRS Part III

S. Zanigni, D. Trundell, A. Monnet, N. Shariati, E. Moore, E. Davies, N. Pross, G. Pagano, T. Nikolcheva (Basel, Switzerland)

Functional Rating Scale 2.0 (FuRST2.0), a patient reported outcome measure for Huntington’s disease: The importance of the patient voice in scale development

R. Fuller, P. Feigenbaum, N. Lapelle, S. Sathe, C. Fitzer-Attas, M. Guttman, C. Goetz, S. Luo, B. Tilley, P. Dalal, C. Sampaio, G. Stebbins (Princeton, USA)

Huntington’s Disease, Cognition, and Fear of Falling

A. Sethi, S. Baek, O. Kaczmarek, B. Bumstead, M. Buhse, M. Zarif, M. Gudesblatt (Patchogue, USA)

In-home remote assessment of the MDS-UPDRS Part III: multi-cultural development and validation of a guide for patients and care partners

M. Tosin, A. Ferro, R. Wu, P. Rabano, P. Martinez-Martin, C. Goetz, G. Stebbins, T. Mestre (Chicago, USA)

Mapping of the International Classification of Functioning, Disability and Health categories in the Pre-Assessment Information Form for People with Parkinson’s Disease.

F. Rogatto, E. Guelfi, G. Pereira, S. Silva (São Paulo, Brazil)

Parkinson’s Disease and Psychosocial Impact: Anxiety, Depression and Positive Symptoms

O. Kaczmarek, S. Baek, A. Sethi, A. Stolarczyk, B. Bumstead, B. Anand, M. Buhse, M. Zarif, M. Gudesblatt (Patchogue, USA)

Parkinson’s Disease, Cognition, Positive Symptoms and Medication Management

O. Kaczmarek, S. Baek, A. Sethi, A. Stolarczyk, B. Bumstead, M. Buhse, M. Zarif, B. Anand, M. Gudesblatt (Patchogue, USA)

The agreement between automated and expert FOG annotations during an at-home protocol: influence of dopaminergic medication and task

N. D'Cruz, D. Zoetewei, T. Herman, P. Ginis, J. Hausdorff, A. Nieuwboer (Leuven, Belgium)

The reliability and validity of the Ziegler test for measuring freezing of gait in people with Parkinson’s disease.

L. Goh, S. Paul, C. Canning, K. Ehgoetz Martens, J. Song, S. Campoy, N. Allen (Camperdown, Australia)

Understanding patient perceptions of the key components of Medication Adherence in PD: a multicenter, international study

M. Tosin, C. Goetz, D. Hall, G. Stebbins, B. Oliveira (Chicago, USA)

Utilisation of the Clinical Frailty Scale to prompt transfer of patients with Parkinson’s disease from Neurology to Geriatric Medicine services.

A. Thomson, T. Jones, C. Chan, C. Miller (Salford, United Kingdom)